Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 26.71 % in the past year, decrease in net sales/revenue by -2.7 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 80 %. Marginal decrease of -36.3% in other income during this quarter.
- Profit over the Year and quarter: Significant improvement in profitability for Lincoln Pharmaceuticals ltd.. Notable increase of 48.04 % in net profit Year to Year, Lincoln Pharmaceuticals ltd.’s profitability dropped by -33.68 % Quarter to Quarter.
- EPS over the Year and quarter: EPS increased by 48.01 % Year to Year. EPS decreased by -33.71 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 112.46 Cr | Rs. 146.449 Cr | Rs. 142.493 Cr | -2.7 % | + 26.71 % |
| Expenses | Rs. 95.82 Cr | Rs. 116.78 Cr | Rs. 124.11 Cr | + 6.28 % | + 29.52 % |
| Operating Profit | Rs. 16.64 Cr | Rs. 29.67 Cr | Rs. 18.38 Cr | -38.05 % | + 10.46 % |
| OPM % | 14.8 % | 20.26 % | 12.9 % | -7.36 % | -1.9 % |
| Other Income | Rs. 3.9 Cr | Rs. 11.02 Cr | Rs. 7.02 Cr | -36.3 % | + 80 % |
| Interest | Rs. 1.15 Cr | Rs. 0.16 Cr | Rs. 0.5 Cr | + 212.5 % | -56.52 % |
| Depreciation | Rs. 2.41 Cr | Rs. 2.81 Cr | Rs. 2.69 Cr | -4.27 % | + 11.62 % |
| Profit before tax | Rs. 16.98 Cr | Rs. 37.72 Cr | Rs. 22.21 Cr | -41.12 % | + 30.8 % |
| Tax % | 26.01 % | 25.64 % | 16.29 % | -9.35 % | -9.72 % |
| Net Profit | Rs. 12.56 Cr | Rs. 28.04 Cr | Rs. 18.6 Cr | -33.67 % | + 48.09 % |
| EPS in Rs | Rs. 6.27 | Rs. 14 | Rs. 9.28 | -33.71 % | + 48.01 % |
Today, we’re looking at Lincoln Pharmaceuticals ltd.’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 26.71 %. However, it did see a marginal slip of -2.7 % from the previous quarter. Expenses ticked up slightly by 6.28 % quarter-on-quarter, aligning with the annual rise of 29.52 %. Operating profit, while up 10.46 % compared to last year, faced a quarter-on-quarter dip of -38.05 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -1.9 %, but a shrinkage of -7.36 % sequentially. Other income fell by -36.3 % compared to the last quarter, despite an annual growth of 80 %. Interest expenses surged remarkably by 212.5 % from the previous quarter, yet the year-over-year decrease remains at a moderate -56.52 %. Depreciation costs fell by -4.27 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 11.62 %. Profit before tax grew annually by 30.8 % but saw a reduction from the preceding quarter by -41.12 %.
Tax expenses as a percentage of profits decreased slightly by -9.72 % compared to last year, with a more notable quarter-on-quarter decrease of -9.35 %. Net profit rose by 48.09 % year-on-year but witnessed a -33.67 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 48.01 % but a quarterly fall of -33.71 %. In summary, Lincoln Pharmaceuticals ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 112.46 Cr | Rs. 146.449 Cr | Rs. 142.493 Cr | -2.7 % | + 26.71 % |
| Expenses | Rs. 95.82 Cr | Rs. 116.78 Cr | Rs. 124.11 Cr | + 6.28 % | + 29.52 % |
| Operating Profit | Rs. 16.64 Cr | Rs. 29.67 Cr | Rs. 18.38 Cr | -38.05 % | + 10.46 % |
| Net Profit | Rs. 12.56 Cr | Rs. 28.04 Cr | Rs. 18.6 Cr | -33.67 % | + 48.09 % |
| EPS in Rs | Rs. 6.27 | Rs. 14 | Rs. 9.28 | -33.71 % | + 48.01 % |
In reviewing Lincoln Pharmaceuticals ltd.’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 26.71 % year-on-year growth, although there was a slight dip of -2.7 % from the previous quarter. Expenses rose by 29.52 % compared to the previous year, with a 6.28 % increase quarter-on-quarter. Operating Profit surged by 10.46 % annually, and saw a -38.05 % decrease from the last quarter.
Net Profit showed yearly increase of 48.09 %, and experienced a -33.67 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 48.01 % annually, however dipped by -33.71 % compared to the last quarter. In essence, while Lincoln Pharmaceuticals ltd. exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
